Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8211591 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 8 Pages |
Abstract
For 9 of 15 NSCLC patients, IMPT in breath-hold was both dosimetrically robust and feasible to deliver regarding the treatment time. Three patients would have required plan adaption to meet the dosimetric criteria. The change in water-equivalent path length is an indicator of plan robustness and should be considered for the selection of patients for whom the plan would require adaptation.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jenny MSc, Per PhD, Rosalind PhD, Gitte F. MD, Mirjana MSc, Maria Francesca MSc, Svend Aage MD, Damien C. MD, Antony J. PhD,